Y-Intercept (HK)’s Vaxart VXRT Stock Holding History

Y-Intercept (HK)’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-91,765	Closed	-$119K	–	1972
2024 Q1	$119K	Buy	+91,765	New	+$96.1K	0.01%	1259
2023 Q3	–	Sell	-216,851	Closed	-$158K	–	1663
2023 Q2	$158K	Buy	+216,851	New	+$202K	0.02%	977
2023 Q1	–	Sell	-125,502	Closed	-$121K	–	1574
2022 Q4	$121K	Buy	+125,502	New	+$177K	0.02%	886
2022 Q3	–	Sell	-10,665	Closed	-$37K	–	1300
2022 Q2	$37K	Buy	+10,665	New	+$39.8K	﹤0.01%	769

Other funds holding VXRT

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Y-Intercept (HK)'s VXRT Position: Q2 2024 in Review

Y-Intercept (HK) sold out of Vaxart (VXRT) in Q2 2024, closing a stake of 91,765 shares — an estimated $119K sold.

Y-Intercept (HK) first reported a position in VXRT in Q2 2022 and held it in 4 quarters. The position peaked at $158K in Q2 2023. 100 funds tracked by Wall St. Rank hold VXRT as of Q2 2024.

Y-Intercept (HK) reported no remaining Vaxart position as of Q2 2024 after selling out during the quarter.
Y-Intercept (HK) sold 91,765 Vaxart shares in Q2 2024, an estimated $119K.
Y-Intercept (HK) first reported a position in Vaxart in Q2 2022 and held it in 4 quarters.
Y-Intercept (HK)'s Vaxart position peaked at $158K in Q2 2023.
100 funds tracked by Wall St. Rank held Vaxart as of Q2 2024.

Based on Y-Intercept (HK)'s 13F filing for Q2 2024, filed 14 Aug 2024.